サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424093

オキシコドン医薬品市場、シェア、規模、動向、産業分析レポート：薬物タイプ別、剤形別、流通チャネル別、地域別、セグメント別予測、2024年～2032年

Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
オキシコドン医薬品市場、シェア、規模、動向、産業分析レポート：薬物タイプ別、剤形別、流通チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のオキシコドン医薬品市場規模は2032年までに82億9,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

がん、関節リウマチ、腰痛、線維筋痛症などの慢性疼痛疾患の罹患率の上昇が、オキシコドン市場拡大の主な要因です。さらに、重度の疼痛管理の治療において他の薬剤が示さない反応性が、オキシコドン医薬品剤の需要を高めています。さらに、これらの薬剤の有望な結果や徐放性オキシコドン医薬品剤に関連する利点が、その処方量を増加させています。さらに、オキシコドン医薬品の優れたコンプライアンスと、投与間隔が短くて済むという利便性が、今後数年間の市場成長の原動力となると思われます。

また、徐放性カプセルの登場と成人の激痛の有病率の高さも市場成長を後押ししています。さらに、市場参入企業が保有する特許と、マーケティングやプロモーションにかける費用の増加が、市場成長に寄与すると思われます。例えば、コレギウム・ファーマシューティカル社のXtampza ERは、2036年まで特許保護を受けています。

また、オキシコドン製剤が他のオピオイド製剤よりも有望な結果を示していることも、市場成長の原動力となっています。さらに、徐放性製剤のようなドラッグ・デリバリー・システムの進歩を伴う新薬の登場は、オキシコドン医薬品市場の成長に長期的な機会をもたらすと思われます。手術後の激痛を和らげるオキシコドンの能力は、外科手術の増加と相まって、市場拡大をサポートすると予想されます。

痛みを和らげる薬としてオキシコドンが広く受け入れられていることと、手術後の疼痛管理のためにオキシコドンに対するニーズが高まっていることが、市場成長を後押しする要因となっています。さらに、未開拓の市場における規制当局の承認に企業が強い関心を寄せていることも、市場成長にプラスの影響を与えるでしょう。さらに、運動不足、タバコの使用、肥満が慢性疼痛に悩む患者数を増加させています。例えば、世界肥満連合によるWorld Obesity Atlas 2023 Reportによると、世界の過体重または肥満の人の数は2020年の26億人から40億人に増加すると予想されています。疼痛管理薬を必要とするこのような肥満の人々が、予測期間中の市場成長を牽引すると思われます。

オキシコドン医薬品市場レポートハイライト

疼痛管理を改善し、疼痛強度のばらつきを抑えるという利点から、長時間作用型セグメントが市場を独占しています。

徐放性カプセルの出現により、カプセル剤セグメントは最も高いCAGRで拡大すると予測されます。

病院分野は、外科手術の増加や入院患者の増加により、最大の市場シェアを占めています。

北米は、大量のオキシコドン処方と慢性疼痛疾患の増加により、市場を独占しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のオキシコドン医薬品市場に関する洞察

  • オキシコドン医薬品市場- 流通チャネルのスナップショット
  • オキシコドン医薬品市場力学
    • 促進要因と機会
      • 慢性疼痛の発生率の上昇がオキシコドン市場の拡大を支援すると予想される
      • オキシコドン医薬品の費用の増加は、市場成長の長期的な機会を提供します
    • 抑制要因と課題
      • オキシコドンのいくつかのリスクと厳格な規制が市場の成長を妨げると予想される
  • PESTEL分析
  • オキシコドン医薬品市場流通チャネルの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のオキシコドン医薬品市場、薬剤タイプ別

  • 主な調査結果
  • イントロダクション
  • 短時間作用型
  • 長時間作用型

第6章 世界のオキシコドン医薬品市場、剤形別

  • 主な調査結果
  • イントロダクション
  • 錠剤
  • カプセル
  • 注射

第7章 世界のオキシコドン医薬品市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 世界のオキシコドン医薬品市場、地域別

  • 主な調査結果
  • イントロダクション
    • オキシコドン医薬品市場評価、地域別、2019-2032年
  • オキシコドン医薬品市場-北米
    • 北米：オキシコドン医薬品市場、薬剤タイプ別、2019-2032年
    • 北米：オキシコドン医薬品市場、流通チャネル別、2019-2032年
    • 北米：オキシコドン医薬品市場、剤形別、2019-2032年
    • オキシコドン医薬品市場-米国
    • オキシコドン医薬品市場- カナダ
  • オキシコドン医薬品市場- 欧州
    • 欧州：オキシコドン医薬品市場、薬剤タイプ別、2019～2032年
    • 欧州：オキシコドン医薬品市場、流通チャネル別、2019-2032
    • 欧州：オキシコドン医薬品市場、剤形別、2019-2032年
    • オキシコドン医薬品市場- 英国
    • オキシコドン医薬品市場- フランス
    • オキシコドン医薬品市場- ドイツ
    • オキシコドン医薬品市場- イタリア
    • オキシコドン医薬品市場- スペイン
    • オキシコドン医薬品市場- オランダ
    • オキシコドン医薬品市場- ロシア
  • オキシコドン医薬品市場- アジア太平洋
    • アジア太平洋：オキシコドン医薬品市場、薬剤タイプ別、2019～2032年
    • アジア太平洋：オキシコドン医薬品市場、流通チャネル別、2019-2032年
    • アジア太平洋：オキシコドン医薬品市場、剤形別、2019-2032年
    • オキシコドン医薬品市場- 中国
    • オキシコドン医薬品市場- インド
    • オキシコドン医薬品市場- マレーシア
    • オキシコドン医薬品市場- 日本
    • オキシコドン医薬品市場- インドネシア
    • オキシコドン医薬品市場- 韓国
  • オキシコドン医薬品市場-中東およびアフリカ
    • 中東およびアフリカ：オキシコドン医薬品市場、薬剤タイプ別、2019～2032年
    • 中東およびアフリカ：オキシコドン医薬品市場、流通チャネル別、2019-2032
    • 中東およびアフリカ：オキシコドン医薬品市場、剤形別、2019-2032年
    • オキシコドン医薬品市場- サウジアラビア
    • オキシコドン医薬品市場- アラブ首長国連邦
    • オキシコドン医薬品市場- イスラエル
    • オキシコドン医薬品市場- 南アフリカ
  • オキシコドン医薬品市場-ラテンアメリカ
    • ラテンアメリカ：オキシコドン医薬品市場、薬剤タイプ別、2019-2032年
    • ラテンアメリカ：オキシコドン医薬品市場、流通チャネル別、2019-2032
    • ラテンアメリカ：オキシコドン医薬品市場、剤形別、2019-2032年
    • オキシコドン医薬品市場- メキシコ
    • オキシコドン医薬品市場- ブラジル
    • オキシコドン医薬品市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Acura Pharmaceuticals（U.S.）
  • Alvogen（U.S.）
  • Amneal Pharmaceuticals LLC.（U.S.）
  • Ascent Pharmaceuticals, Inc.（U.S.）
  • Collegium Pharmaceutical（U.S.）
  • Endo International plc（Ireland）
  • Epic Pharma, LLC.（U.S.）
  • Mallinckrodt（Ireland）
  • Mundipharma International（UK）
  • Pfizer Inc.（U.S.）
  • Protega Pharmaceuticals Inc.（U.S.）
  • Rhodes Pharmaceuticals L.P.（U.S.）
  • Sun Pharmaceutical Industries Ltd.（India）
図表

List of Tables

  • Table 1 Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 2 Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 3 Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 6 North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 7 North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 10 U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 13 Canada: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 16 Europe: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 19 UK: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 21 France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 22 France: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 25 Germany: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 28 Italy: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 31 Spain: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 37 Russia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 42 China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 43 China: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 45 India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 46 India: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 52 Japan: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 58 South Korea: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 67 UAE: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 70 Israel: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 73 South Africa: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 76 Latin America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 79 Mexico: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 82 Brazil: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 85 Argentina: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Oxycodone Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Dosage Form
  • Figure 7. Global Oxycodone Drugs Market, by Dosage Form, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Oxycodone Drugs Market, by Drug Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Oxycodone Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Oxycodone Drugs Market
目次
Product Code: PM4347

The global oxycodone drugs market size is expected to reach USD 8.29 billion by 2032, according to a new study by Polaris Market Research. The report "Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising incidence of chronic pain disease such as cancer, rheumatoid arthritis, lower back pain, and fibromyalgia is the primary contributor for the oxycodone market expansion. Moreover, the unresponsiveness shown by other medications for the treatment of severe pain management has increased the demand for oxycodone drugs. Furthermore, promising results of these drugs and benefits associated with the extended release oxycodone drugs has increased its prescription volumes. Additionally, better compliance and convenience of less-frequent dosage intervals offered by oxycodone drugs will fuel the market growth in the coming years.

The advent of extended-release capsules coupled with the high prevalence of severe pain among adults are also propelling the market growth. Moreover, the patents owned by market players coupled with their increasing expenses on marketing and promotion will contribute to the market growth. For instance, Collegium Pharmaceutical's Xtampza ER has patent protection until 2036.

The promising results shown by the oxycodone drugs over other opioid medications is also driving the market growth. Moreover, the advent of new drugs with advancements in drug delivery systems such as extended-release formulations will provide long-term opportunity for the oxycodone drugs market growth. The ability of oxycodone to lower the severe pain after surgery coupled with an increasing number of surgical procedures are expected to support the market expansion.

The widespread acceptance of oxycodone drugs as a pain-relieving medication and growing need for oxycodone for the pain management after surgeries are the factors propelling the market growth. Moreover, the strong focus of companies on the regulatory approvals in untapped markets will positively influence the market growth. Furthermore, lack of physical activities, tobacco usage, and obesity are increasing the number of patients suffering from chronic pain. For instance, according to the World Obesity Atlas 2023 Report by the World Obesity Federation, the number of people with overweight or obesity worldwide is expected to increase to 4.0 billion, from 2.6 billion in 2020. Such obese people requiring pain management medications will drive the market growth during the forecast period.

Oxycodone Drugs Market Report Highlights

The long-acting segment dominated the market, owing to its benefits for improving pain management and reducing pain intensity variations.

The capsules segment is expected to expand at the highest CAGR, owing to the emergence of extended release capsules.

Hospital segment held the largest market share, owing to the increasing number of surgical procedures and rising hospital admissions.

North America dominated the market, owing to the large volume of oxycodone prescriptions and rising incidences of chronic pain diseases.

The market players include Collegium Pharmaceutical, Mundipharma International, Sun Pharmaceutical Industries Ltd., Endo International plc, and Mallinckrodt.

Polaris Market Research has segmented the oxycodone drugs market report based on drug type, dosage form, distribution channel, and region:

Oxycodone Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Short-acting
  • Long-acting

Oxycodone Drugs, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tablet
  • Capsule
  • Injection

Oxycodone Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Oxycodone Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oxycodone Drugs Market Insights

  • 4.1. Oxycodone Drugs Market - Distribution Channel Snapshot
  • 4.2. Oxycodone Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of chronic pain is expected to support the oxycodone market expansion
      • 4.2.1.2. Increasing expenses for oxycodone drugs will provide a long-term opportunity for the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Several risks of oxycodone coupled with strict regulations is expected to hamper the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Oxycodone Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oxycodone Drugs Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Short-acting
    • 5.3.1. Global Oxycodone Drugs Market, by Short-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Long-acting
    • 5.4.1. Global Oxycodone Drugs Market, by Long-acting, by Region, 2019-2032 (USD Billion)

6. Global Oxycodone Drugs Market, by Dosage Form

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 6.3. Tablet
    • 6.3.1. Global Oxycodone Drugs Market, by Tablet, by Region, 2019-2032 (USD Billion)
  • 6.4. Capsule
    • 6.4.1. Global Oxycodone Drugs Market, by Capsule, by Region, 2019-2032 (USD Billion)
  • 6.5. Injection
    • 6.5.1. Global Oxycodone Drugs Market, by Injection, by Region, 2019-2032 (USD Billion)

7. Global Oxycodone Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Oxycodone Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Oxycodone Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Oxycodone Drugs Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Oxycodone Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Oxycodone Drugs Market - North America
    • 8.3.1. North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.4. Oxycodone Drugs Market - U.S.
      • 8.3.4.1. U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.5. Oxycodone Drugs Market - Canada
      • 8.3.5.1. Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.4. Oxycodone Drugs Market - Europe
    • 8.4.1. Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.4. Oxycodone Drugs Market - UK
      • 8.4.4.1. UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.5. Oxycodone Drugs Market - France
      • 8.4.5.1. France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.6. Oxycodone Drugs Market - Germany
      • 8.4.6.1. Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.7. Oxycodone Drugs Market - Italy
      • 8.4.7.1. Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.8. Oxycodone Drugs Market - Spain
      • 8.4.8.1. Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.9. Oxycodone Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.10. Oxycodone Drugs Market - Russia
      • 8.4.10.1. Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.5. Oxycodone Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.4. Oxycodone Drugs Market - China
      • 8.5.4.1. China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.5. Oxycodone Drugs Market - India
      • 8.5.5.1. India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.6. Oxycodone Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.7. Oxycodone Drugs Market - Japan
      • 8.5.7.1. Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.8. Oxycodone Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.9. Oxycodone Drugs Market - South Korea
      • 8.5.9.1. South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.6. Oxycodone Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.4. Oxycodone Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.5. Oxycodone Drugs Market - UAE
      • 8.6.5.1. UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.6. Oxycodone Drugs Market - Israel
      • 8.6.6.1. Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.7. Oxycodone Drugs Market - South Africa
      • 8.6.7.1. South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.7. Oxycodone Drugs Market - Latin America
    • 8.7.1. Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.4. Oxycodone Drugs Market - Mexico
      • 8.7.4.1. Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.5. Oxycodone Drugs Market - Brazil
      • 8.7.5.1. Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.6. Oxycodone Drugs Market - Argentina
      • 8.7.6.1. Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Acura Pharmaceuticals (U.S.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2.Alvogen (U.S.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amneal Pharmaceuticals LLC. (U.S.)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ascent Pharmaceuticals, Inc. (U.S.)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Collegium Pharmaceutical (U.S.)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Endo International plc (Ireland)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Epic Pharma, LLC. (U.S.)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mallinckrodt (Ireland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mundipharma International (UK)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer Inc. (U.S.)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Protega Pharmaceuticals Inc. (U.S.)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Rhodes Pharmaceuticals L.P. (U.S.)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Pharmaceutical Industries Ltd. (India)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development